
Obesity has developed into a major global epidemic during the past few years. Increased consumption of more energy-dense, nutrient poor foods with high levels of sugar and saturated fats, combined with reduced physical activity, have resulted in obesity rates that have risen three-fold or more since 1980 all around the globe. With such stupendous rise in the prevalence rate, the demand for obesity drugs will also rise. Due to this, the global obesity market is expected to grow at a CAGR of around 13% during 2012 - 2013, says our new research report “Global Obesity Drug Market Analysis”.